A phase 1 clinical trial of sequential pralatrexate followed by a 48‐hour infusion of 5‐fluorouracil given every other week in adult patients with solid tumors

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|21|3862-3868

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.21, 2015-11, pp. : 3862-3868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract